6-K - Dr. Reddy's Laboratories Limited | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

Dr. Reddy's Laboratories Limited disclosed an amended 'Code of Practices and Procedures for Fair Disclosures of Un-published Price Sensitive Information' approved by the Board on March 24, 2026, in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. This update ensures uniform dissemination of unpublished price sensitive information to stock exchanges and the company's website.

Key Takeaways

1Board approved amended fair disclosure code on March 24, 2026.

2Disclosure made to National Stock Exchange of India Ltd. (DRREDDY), BSE Limited (500124), New York Stock Exchange Inc. (RDY), and NSE IFSC Ltd. (DRREDDY).

3Code designates Head of Investor Relations as Chief Investor Relations Officer.

Current Report Details

Event Type

Securities Issuance

Disclosure

Voluntary

Variant

6-K

Items Reported

6-K

Current Report on Form 6-K

Securities Issuance

Exhibits (2)

6-K

FORM 6-K

99.1

EXHIBIT 99.1